Marksans Pharma Limited Ibuprofen Export Data — India (DGFT 2022–2026)

Name: Marksans Pharma Limited Ibuprofen Export Records India — #4 Exporter, 1,751 Shipments, $53.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ibuprofen

India Pharmaceutical Trade Intelligence

$584.2M762 Suppliers173 CountriesHS 30049063

ExportsIndia → FRANCE21.6%India → UNITED STATES17.8%

ImportsGERMANY → India$1.4M COSTA RICA → India$120.2K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: VIATRIS SANTE

Marksans Pharma Limited — Ibuprofen Exporter #4 | $53.8M Trade Value | TransData Nexus | TransData Nexus

Marksans Pharma Limited — Ibuprofen Exporter Profile

Indian Pharmaceutical Exporter · #4 for Ibuprofen · $53.8M export value · DGFT Verified

Marksans Pharma Limited is the #4 Indian exporter of Ibuprofen with $53.8M in export value and 1,751 verified shipments. Marksans Pharma Limited holds a 9.2% market share in Ibuprofen exports across 8 countries. The company exports 22 pharmaceutical products worth $125.0M across 11 therapeutic categories.

Marksans Pharma Limited — Ibuprofen Export Profile: Buyers & Destinations

Marksans Pharma Limited Ibuprofen export treemap — buyers and destination countries | TransData Nexus

Where Does Marksans Pharma Limited Export Ibuprofen?

Country	Value	Shipments	Share
UNITED STATES	$46.5M	1,467	67.7%
UNITED KINGDOM	$12.0M	651	17.5%
AUSTRALIA	$7.6M	303	11.0%
CANADA	$2.3M	55

Who Are the Top Buyers of Ibuprofen from Marksans Pharma Limited?

Buyer	Country	Value	Orders
TIME-CAP LABS,	UNITED STATES	$25.0M	771
TIME-CAP LABS INC	UNITED STATES	$8.8M	274
TIME-CAP LABS	UNITED STATES	$4.8M	167
NOVA PHARMACEUTICALS AUSTRALASIA	AUSTRALIA	$4.3M	167
BELLS SONS & CO (DRUGGISTS) LTD.	UNITED KINGDOM	$4.1M	206
BELLS SONS & CO (DRUGGISTS) LTD	UNITED KINGDOM	$3.9M	207
TIME-CAP LABS, INC	UNITED STATES	$3.5M	127
TIME CAP LABS	UNITED STATES	$3.3M	94
NOVA PHARMACEUTICALS AUSTRALASIA PT	AUSTRALIA	$2.6M	103
BELLS SONS CO DRUGGISTS LIMITED	UNITED KINGDOM	$1.8M	79

Marksans Pharma Limited supplies Ibuprofen to 42 buyers globally. The largest buyer is TIME-CAP LABS, (UNITED STATES), followed by TIME-CAP LABS INC (UNITED STATES) and TIME-CAP LABS (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ibuprofen Formulations Does Marksans Pharma Limited Export?

Product Description / Formulation	Value	Shipments
PHARMACEUTICAL PRODUCTS-IBUPROFEN TABLET	$2.7M	65
IBUPROFEN TABLETS USP 200 MG BATCH NO: 1	$2.2M	76
PHARMACEUTICAL PRODUCTS-IBUPROFEN 200MG	$1.9M	99
IBUPROFEN TABLETS USP 200 MG Batch No: 1	$1.7M	52
IBUPROFEN SOFT GELATIN CAPSULES 200 MG B	$1.4M	43
IBUPROFEN SOFT GELATIN CAPSULES 200MG BA	$1.1M	33
IBUPROFEN SOFT GELATIN CAPSULES 200MG Ba	$970.0K	25
PHARMACEUTICAL PRODUCTS-IBUPROFEN SOFT G	$904.4K	22
IBUPROFEN 200MG COATED TABLETS BATCH NO:	$803.9K	51
IBUPROFEN 200MG COATED TABLETS Batch No:	$719.8K	46

Marksans Pharma Limited exports 1429 distinct Ibuprofen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS-IBUPROFEN TABLET with 65 shipments worth $2.7M.

How Does Marksans Pharma Limited Compare to Nearest Ibuprofen Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	MARKSANS PHARMA LIMITED ★	$53.8M	1,751	8	$30.7K
2	GRANULES INDIA LIMITED	$34.9M	698	11	$50.0K
3	CAPLIN POINT LABORATORIES LIMITED	$31.4M	627	9	$50.0K

Marksans Pharma Limited ranks #4 among 762 Indian Ibuprofen exporters. Average shipment value of $30.7K compared to the market average of $278.5K. The closest competitors by value are GRANULES INDIA LIMITED and CAPLIN POINT LABORATORIES LIMITED.

Which Indian Ports Ship Ibuprofen Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	2,511	16.7%
JNPT/ NHAVA SHEVA SEA	1,756	11.7%
JNPT	774	5.2%
SAHAR AIR	637	4.2%
SAHAR AIR CARGO ACC (INBOM4)	593	4.0%
BANGALORE ICD	472	3.1%
NHAVA SHEVA	422	2.8%
CHENNAI SEA	419	2.8%

Geopolitical & Trade Policy Impact on Marksans Pharma Limited's Ibuprofen Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Marksans Pharma. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, a crucial maritime route for trade between Asia and Europe. Major shipping lines have introduced an 'Emergency Risk Surcharge' ranging from $250 to $500 per TEU for cargo transiting the Bab-el-Mandeb Strait, effective February 2025. This surcharge elevates shipping costs, potentially impacting the competitiveness of Indian pharmaceutical exports to European and US East Coast markets. (sgeexport.com)

Conversely, the India–European Union Free Trade Agreement (FTA), concluded in January 2026, offers a silver lining. The FTA eliminates tariffs on Indian pharmaceuticals, APIs, vaccines, and medical devices, providing immediate cost relief and enhancing market access for Indian exporters. This development positions Marksans Pharma favorably to increase its footprint in the European market, leveraging its existing regulatory approvals and manufacturing capabilities. (en.wikipedia.org)

Marksans Pharma Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for pharmaceutical exporters. Marksans Pharma has demonstrated a strong commitment to regulatory compliance. In November 2025, the company's Goa facility underwent a current Good Manufacturing Practice (cGMP) inspection by the US FDA, concluding with zero Form 483 observations. This outcome reflects Marksans' dedication to adhering to international quality standards and regulatory requirements. (capitalmarket.com)

Furthermore, the company's subsidiaries have achieved significant regulatory milestones. Time-Cap Laboratories Inc., Marksans' US subsidiary, received an Establishment Inspection Report (EIR) from the US FDA for its New York-based facility in June 2025, following an inspection that resulted in only one observation with no data integrity issues. Such achievements bolster Marksans' reputation as a reliable and compliant pharmaceutical manufacturer. (business-standard.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ibuprofen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Marksans Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 2,500 individual customs records matching Marksans Pharma Limited exporting Ibuprofen, covering 1429 formulations to 9 countries via 42 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 173+ countries, 2,116+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ibuprofen

Ibuprofen

Marksans Pharma Limited — Ibuprofen Exporter Profile

Marksans Pharma Limited — Ibuprofen Export Profile: Buyers & Destinations

Where Does Marksans Pharma Limited Export Ibuprofen?

Who Are the Top Buyers of Ibuprofen from Marksans Pharma Limited?

What Is India's Total Ibuprofen Export Value and How Much Does Marksans Pharma Limited Contribute?

What Is the Average Shipment Value for Marksans Pharma Limited's Ibuprofen Exports?

How Does Marksans Pharma Limited Compare to Other Indian Ibuprofen Exporters?

What Ibuprofen Formulations Does Marksans Pharma Limited Export?

Regulatory Requirements: Exporting Ibuprofen to Key Markets

United States — FDA

United Kingdom — MHRA

Australia — TGA

How Does Marksans Pharma Limited Compare to Nearest Ibuprofen Exporters?

Which Indian Ports Ship Ibuprofen Exports?

What Other Analgesics & Antipyretics Products Does Marksans Pharma Limited Export?

Ibuprofen — Export Intelligence Video

Geopolitical & Trade Policy Impact on Marksans Pharma Limited's Ibuprofen Exports

Marksans Pharma Limited — Regulatory Compliance & Quality Standards

About Marksans Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ibuprofen Export Data from Marksans Pharma Limited

Ibuprofen Stats

Company Overview

Top Products by Marksans Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source